These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9149911

  • 1. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Szekely L, Pokrovskaja K, Klein G.
    Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins.
    Pokrovskaja K, Trivedi P, Klein G, Szekely L.
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2031-40. PubMed ID: 9267004
    [Abstract] [Full Text] [Related]

  • 3. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K, Ehlin-Henriksson B, Bartkova J, Bartek J, Scuderi R, Szekely L, Wiman KG, Klein G.
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [Abstract] [Full Text] [Related]

  • 4. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.
    J Natl Cancer Inst; 2004 Oct 06; 96(19):1447-57. PubMed ID: 15467034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL, Rowe M, Cope AP, Feldmann M, Brennan FM.
    Eur J Immunol; 1994 Aug 06; 24(8):1879-85. PubMed ID: 8056047
    [Abstract] [Full Text] [Related]

  • 7. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
    Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T, Sculley T.
    Virology; 1998 Dec 20; 252(2):418-30. PubMed ID: 9878621
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J, Ternes P, Lange W, Mertelsmann R, Dölken G.
    Leukemia; 1993 Nov 20; 7(11):1852-7. PubMed ID: 7694007
    [Abstract] [Full Text] [Related]

  • 11. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD, Rowe M, Rickinson AB.
    J Gen Virol; 1990 Jul 20; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [Abstract] [Full Text] [Related]

  • 12. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF, Chen F, Altiok E, Winberg G, Klein G, Ernberg I.
    Gan To Kagaku Ryoho; 2000 May 20; 27 Suppl 2():248-60. PubMed ID: 10895161
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
    Guan M, Romano G, Henderson EE.
    Anticancer Res; 1999 May 20; 19(4B):3007-17. PubMed ID: 10652585
    [Abstract] [Full Text] [Related]

  • 16. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.
    J Med Virol; 2001 Sep 20; 65(1):114-20. PubMed ID: 11505452
    [Abstract] [Full Text] [Related]

  • 17. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T, Nguyen QV, Woda B, Humphreys RE.
    J Immunol; 1987 Apr 15; 138(8):2645-52. PubMed ID: 2435803
    [Abstract] [Full Text] [Related]

  • 18. Human B-lymphoid cell lines.
    Nilsson K.
    Hum Cell; 1992 Mar 15; 5(1):25-41. PubMed ID: 1329931
    [Abstract] [Full Text] [Related]

  • 19. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A, Pfaff P, Lange W, Finke J.
    Cytokines Mol Ther; 1996 Mar 15; 2(1):21-8. PubMed ID: 9384686
    [Abstract] [Full Text] [Related]

  • 20. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
    Staege MS, Lee SP, Frisan T, Mautner J, Scholz S, Pajic A, Rickinson AB, Masucci MG, Polack A, Bornkamm GW.
    Proc Natl Acad Sci U S A; 2002 Apr 02; 99(7):4550-5. PubMed ID: 11917131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.